108 related articles for article (PubMed ID: 11426542)
1. Central nervous system relapse in a patient with mantle cell lymphoma in continuous clinical and molecular remission at six years since autografting.
Ladetto M; Sametti S; Astolfi M; Corradini P; Ricca I; Drandi D; Pileri A; Tarella C
Leuk Lymphoma; 2001 Feb; 40(5-6):679-82. PubMed ID: 11426542
[TBL] [Abstract][Full Text] [Related]
2. Risk factors of central nervous system relapse in mantle cell lymphoma.
Conconi A; Franceschetti S; Lobetti-Bodoni C; Stathis A; Margiotta-Casaluci G; Ramponi A; Mazzucchelli L; Bertoni F; Ghielmini M; Gaidano G; Cavalli F; Zucca E
Leuk Lymphoma; 2013 Sep; 54(9):1908-14. PubMed ID: 23339449
[TBL] [Abstract][Full Text] [Related]
3. Ki-67 is a strong predictor of central nervous system relapse in patients with mantle cell lymphoma (MCL).
Chihara D; Asano N; Ohmachi K; Nishikori M; Okamoto M; Sawa M; Sakai R; Okoshi Y; Tsukamoto N; Yakushijin Y; Nakamura S; Kinoshita T; Ogura M; Suzuki R
Ann Oncol; 2015 May; 26(5):966-973. PubMed ID: 25712457
[TBL] [Abstract][Full Text] [Related]
4. Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years.
Kolstad A; Pedersen LB; Eskelund CW; Husby S; Grønbæk K; Jerkeman M; Laurell A; Räty R; Elonen E; Andersen NS; Brown PD; Kimby E; Bentzen H; Sundström C; Ehinger M; Karjalainen-Lindsberg ML; Delabie J; Ralfkiær E; Fagerli UM; Nilsson-Ehle H; Lauritzsen GF; Kuittinen O; Niemann C; Geisler CH;
Biol Blood Marrow Transplant; 2017 Mar; 23(3):428-435. PubMed ID: 28039078
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypes.
Corradini P; Ladetto M; Zallio F; Astolfi M; Rizzo E; Sametti S; Cuttica A; Rosato R; Farina L; Boccadoro M; Benedetti F; Pileri A; Tarella C
J Clin Oncol; 2004 Apr; 22(8):1460-8. PubMed ID: 15084619
[TBL] [Abstract][Full Text] [Related]
6. Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphoma.
Andersen NS; Pedersen LB; Laurell A; Elonen E; Kolstad A; Boesen AM; Pedersen LM; Lauritzsen GF; Ekanger R; Nilsson-Ehle H; Nordström M; Fredén S; Jerkeman M; Eriksson M; Väärt J; Malmer B; Geisler CH
J Clin Oncol; 2009 Sep; 27(26):4365-70. PubMed ID: 19652064
[TBL] [Abstract][Full Text] [Related]
7. Patterns and outcome of relapse after autologous stem cell transplantation for mantle cell lymphoma.
Dietrich S; Tielesch B; Rieger M; Nickelsen M; Pott C; Witzens-Harig M; Kneba M; Schmitz N; Ho AD; Dreger P
Cancer; 2011 May; 117(9):1901-10. PubMed ID: 21509767
[TBL] [Abstract][Full Text] [Related]
8. Long-term clinical and molecular remissions in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantation.
Metzner B; Müller TH; Gebauer W; Casper J; Kraemer D; Rosien B; Schumann-Binarsch S; Thole R; Köhne CH; Dreyling M; Hoster E; Pott C
Ann Hematol; 2014 May; 93(5):803-10. PubMed ID: 24337447
[TBL] [Abstract][Full Text] [Related]
9. Phase I/II study of bortezomib-BEAM and autologous hematopoietic stem cell transplantation for relapsed indolent non-Hodgkin lymphoma, transformed, or mantle cell lymphoma.
William BM; Allen MS; Loberiza FR; Bociek RG; Bierman PJ; Armitage JO; Vose JM
Biol Blood Marrow Transplant; 2014 Apr; 20(4):536-42. PubMed ID: 24434781
[TBL] [Abstract][Full Text] [Related]
10. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
[TBL] [Abstract][Full Text] [Related]
11. Autografting followed by rituximab for chemosensitive mantle cell lymphoma: a pilot study and literature review.
Grigg AP; Bashford J; Seymour JF; Shuttleworth P; Norris D; Hertzberg M; Gill D; Waugh M; Saal R; Marlton P
Leuk Lymphoma; 2005 Jun; 46(6):851-60. PubMed ID: 16019529
[TBL] [Abstract][Full Text] [Related]
12. Isolated central nervous system (CNS) relapse in a case of childhood systemic anaplastic large cell lymphoma without initial CNS involvement.
Mori T; Sugita K; Kimura K; Fuke T; Miura T; Kiyokawa N; Fujimoto J
J Pediatr Hematol Oncol; 2003 Dec; 25(12):975-7. PubMed ID: 14663283
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma.
Mangel J; Buckstein R; Imrie K; Spaner D; Crump M; Tompkins K; Reis M; Perez-Ordonez B; Deodhare S; Romans R; Pennell N; Robinson JB; Hewitt K; Richardson P; Lima A; Pavlin P; Berinstein NL
Semin Oncol; 2002 Feb; 29(1 Suppl 2):56-69. PubMed ID: 11842390
[TBL] [Abstract][Full Text] [Related]
14. Mantle cell lymphoma with central nervous system involvement: frequency and clinical features.
Gill S; Herbert KE; Prince HM; Wolf MM; Wirth A; Ryan G; Carney DA; Ritchie DS; Davies JM; Seymour JF
Br J Haematol; 2009 Oct; 147(1):83-8. PubMed ID: 19694718
[TBL] [Abstract][Full Text] [Related]
15. Autotransplantation for mantle cell lymphoma.
Vose JM
Cancer J; 2012; 18(5):427-31. PubMed ID: 23006947
[TBL] [Abstract][Full Text] [Related]
16. Central nervous system involvement by mantle cell lymphoma.
McLaughlin N; Wang Y; Witzig T; Villasboas J; Habermann T; Inwards D; Bennani N; Thanarajasingam G; Nowakowski G; Porrata L; Thompson C; Micallef I; Johnston P; Ansell S; Paludo J
Leuk Lymphoma; 2023 Feb; 64(2):371-377. PubMed ID: 36416595
[TBL] [Abstract][Full Text] [Related]
17. Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Vaughn JE; Sorror ML; Storer BE; Chauncey TR; Pulsipher MA; Maziarz RT; Maris MB; Hari P; Laport GG; Franke GN; Agura ED; Langston AA; Rezvani AR; Storb R; Sandmaier BM; Maloney DG
Cancer; 2015 Oct; 121(20):3709-16. PubMed ID: 26207349
[TBL] [Abstract][Full Text] [Related]
18. Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphoma.
Yamasaki S; Chihara D; Kim SW; Izutsu K; Iwato K; Fukuda T; Uchida N; Amano I; Nakazawa H; Kuroda J; Hashimoto H; Ichinohe T; Kanda Y; Atsuta Y; Suzumiya J; Suzuki R
Ann Hematol; 2018 Aug; 97(8):1445-1452. PubMed ID: 29610968
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of autologous stem cell transplantation in mantle cell lymphoma: a 3-year follow-up study.
Decaudin D; Brousse N; Brice P; Haioun C; Bourhis JH; Morel P; Van Hoof A; Souleau B; Quesnel B; Gisselbrecht C
Bone Marrow Transplant; 2000 Feb; 25(3):251-6. PubMed ID: 10673695
[TBL] [Abstract][Full Text] [Related]
20. Very late isolated CNS relapse of acute myeloid leukemia.
Molina B; Lassaletta A; Gonzalez-Vicent M; Andión M; Diaz MA; Madero L
J Pediatr Hematol Oncol; 2013 Mar; 35(2):e57-9. PubMed ID: 23412589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
